Collecting and Storing Samples From Patients With Lung Cancer

This study is currently recruiting participants.

Verified by National Cancer Institute (NCI), February 2010

First Received: June 11, 2009 Last Updated: February 5, 2010 History of Changes

Sponsor:	Southwest Oncology Group
Collaborator:	National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00920010

Purpose

RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.

Condition	Intervention
Lung Cancer	Other: biologic sample preservation procedure

Study Type:	Observational
Official Title:	Lung Cancer Specimen Repository Protocol, Ancillary

Resource links provided by NLM:

MedlinePlus related topics: Cancer Lung Cancer

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies [ Designated as safety issue: No ]
Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository [ Designated as safety issue: No ]
Test of new hypotheses with the specimens in the repository [ Designated as safety issue: No ]

Study Start Date:

September 2000

Detailed Description:

OBJECTIVES:

Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
Test new hypotheses with the specimens in the repository.

OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.

PROJECTED ACCRUAL: Not specified

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Enrolled on one of the following Southwest Oncology Group protocols:
- SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124

PATIENT CHARACTERISTICS: Not specified

PRIOR CONCURRENT THERAPY: Not specified

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00920010

Show 425 Study Locations

Sponsors and Collaborators

Southwest Oncology Group

National Cancer Institute (NCI)

Investigators

Study Chair:

Wilbur A. Franklin, MD

University of Colorado, Denver

More Information

Additional Information:

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	CDR0000078624, SWOG-S9925
Study First Received:	June 11, 2009
Last Updated:	February 5, 2010
ClinicalTrials.gov Identifier:	NCT00920010 History of Changes
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

non-small cell lung cancer
small cell lung cancer

Additional relevant MeSH terms:

Thoracic Neoplasms
Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site

Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases

ClinicalTrials.gov processed this record on February 08, 2010